MRT Inc.

TSE:6034 Stock Report

Market Cap: JP¥4.0b

MRT Past Earnings Performance

Past criteria checks 0/6

MRT has been growing earnings at an average annual rate of 12.5%, while the Healthcare industry saw earnings growing at 6.1% annually. Revenues have been growing at an average rate of 14.6% per year.

Key information

12.5%

Earnings growth rate

12.5%

EPS growth rate

Healthcare Industry Growth7.9%
Revenue growth rate14.6%
Return on equity-3.8%
Net Margin-3.5%
Last Earnings Update30 Sep 2024

Recent past performance updates

Recent updates

Slammed 32% MRT Inc. (TSE:6034) Screens Well Here But There Might Be A Catch

Aug 05
Slammed 32% MRT Inc. (TSE:6034) Screens Well Here But There Might Be A Catch

Revenue & Expenses Breakdown

How MRT makes and spends money. Based on latest reported earnings, on an LTM basis.

Earnings and Revenue History

TSE:6034 Revenue, expenses and earnings (JPY Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Sep 244,212-1492,6220
30 Jun 244,387322,5070
31 Mar 244,5791602,4210
31 Dec 235,4075172,3040
30 Sep 236,0971,0242,4100
30 Jun 236,5331,3072,3830
31 Mar 238,1691,8762,4310
31 Dec 228,7382,1592,4360
30 Sep 228,2001,8012,2580
30 Jun 228,2691,9372,3210
31 Mar 226,2721,3902,1170
31 Dec 214,4697741,9480
30 Sep 213,8927311,7480
30 Jun 212,9142561,4770
31 Mar 212,514831,3760
31 Dec 202,5621311,3380
31 Dec 192,478251,3710
30 Sep 192,374351,4560
30 Jun 192,236811,4440
31 Mar 192,232971,4700
31 Dec 182,0981731,3470
30 Sep 181,9301291,2740
30 Jun 181,815681,1510
31 Mar 181,501319890
31 Dec 171,43559500
30 Sep 171,350718390
30 Jun 171,256807760
31 Mar 171,154887220
31 Dec 161,0741146930
31 Mar 161,0011406240

Quality Earnings: 6034 is currently unprofitable.

Growing Profit Margin: 6034 is currently unprofitable.

Free Cash Flow vs Earnings Analysis

Past Earnings Growth Analysis

Earnings Trend: 6034 is unprofitable, but has reduced losses over the past 5 years at a rate of 12.5% per year.

Accelerating Growth: Unable to compare 6034's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: 6034 is unprofitable, making it difficult to compare its past year earnings growth to the Healthcare industry (7.2%).

Return on Equity

High ROE: 6034 has a negative Return on Equity (-3.8%), as it is currently unprofitable.

Return on Assets

Return on Capital Employed

Discover strong past performing companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/01/16 05:46
End of Day Share Price 2025/01/16 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

MRT Inc. is covered by 1 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Satoshi TanakaDaiwa Securities Co. Ltd.